Baijin Life Science Holdings Limited (MNNGF)
Baijin Life Science Holdings Limited operates in the Luxury Goods industry of the Consumer Cyclical sector, headquartered in Hong Kong, HK. The stock last traded at $0.15, up 0.00% on the session, giving a market capitalisation of $139.8M. On trailing twelve-month figures it carries a trailing P/E of -23.98, a net margin of -42.4%. Its beta of -0.32 implies it has historically moved less than the broad market.
Baijin Life Science Holdings Limited, an investment holding entity founded in 2014 and situated in Central, Hong Kong, conducts various operations. Its core business involves the full lifecycle of pearls and jewelry products, including their acquisition, processing, design, manufacturing, assembly, trading, and wholesale distribution. The company's activities are structured into two distinct divisions: the sale of pearl and jewelry items, and strategic investment alongside financial services. Additionally, it allocates capital to financial assets within the real estate sector. Baijin Life Science operates internationally, with a footprint in Hong Kong, the United Kingdom, the United States, Japan, Europe, and mainland China.